Table 1.
Stem cells that are implicated in the cell-based therapy for retinal diseases.
| Source | Stem/progenitor markers | Reference |
|---|---|---|
| Hematopoietic stem cells (HSC) | CD44hi/CD11a+/CD11b+/Ly6G/C+/F4/80+/CD14, cKit+ | (15) |
| Endothelial progenitor (EPC) | CD34+ | (18) |
| Embryonic stem cells | CD31+/CD146+ | (70, 71) |
| Induced pluripotent stem cells (iPSC) | CD31+/CD146+ | (70, 72) |
| Umbilical cord blood (UCB)-derived myeloid progenitor cells | CD14+ | (73) |
| Mesenchymal stem cells (MSC) | CD31−/CD34−/CD44+/CD45−/CD73+/CD90+/CD105+/CD140b+ | (43, 45) |
A limited compilation of stem cells that are implicated in retinal diseases with specific emphasis on retinopathy where applicable.